Fecal Metagenomics and Antimicrobial Resistance in Dogs and Cats

Australia has one of the highest pet ownership rates in the world, with more than 5 million dogs and 5.3 million cats sharing homes from Sydney terraces to outback stations. This density, combined with a culture of off-leash beach walks and bushland hikes, places Australian practitioners at the frontline of resistance surveillance. Fecal metagenomic analysis offers a culture-free window into the resistance genes circulating in companion animal guts, complementing traditional susceptibility testing and informing stewardship decisions.

Shotgun sequencing of canine and feline stool samples detects hundreds of antimicrobial resistance genes in a single assay, including those carried by unculturable organisms. For clinics in Melbourne, Brisbane, or Perth that lack reference laboratory access, the approach is valuable when investigating recurrent diarrhoea, treatment failure, or multi-drug resistant infections. Understanding what the technology delivers, and what it does not, is becoming essential to modern small animal practice.

The resistome in companion animals

The resistome refers to the full collection of antimicrobial resistance genes present in a microbial community, regardless of whether the host bacteria are currently pathogenic. In dogs and cats, this includes genes encoding beta-lactamases, tetracycline efflux pumps, aminoglycoside modifying enzymes, and the mobile colistin resistance determinant mcr-1. Healthy pets already carry a baseline resistome shaped by diet, environment, and prior antibiotic exposure, and this baseline shifts measurably after treatment.

Fecal metagenomics captures resistance determinants from both dominant microbiota and low-abundance minority populations that routine culture would miss. Resistance genes transfer horizontally between commensals and opportunistic pathogens such as Escherichia coli, Enterococcus species, and Clostridioides difficile. The technique offers a more complete picture of carriage, including the silent reservoir that may emerge during stress, immunosuppression, or hospitalisation.

How the sequencing workflow operates

A typical workflow begins with a freshly passed or refrigerated stool sample, ideally collected before antibiotics are administered where clinically feasible. DNA is extracted, fragmented, and prepared into genomic libraries that are sequenced on a high-throughput platform. Bioinformatics pipelines assemble reads, annotate open reading frames, and query curated databases such as ResFinder, CARD, and MEGARes to identify known resistance determinants.

Sequencing depth determines what can be detected. Low-depth runs profile the most abundant taxa and their dominant resistance genes, while deeper sequencing is required to investigate low-prevalence carriage. Turnaround times have shortened, with some services returning resistome profiles within seven to ten working days, fitting the diagnostic window for many chronic enteropathy cases discussed in this microbiome analysis resource. Cost remains a consideration, though prices have fallen steadily.

Clinical applications across Australian practice

Australian veterinarians encounter a distinctive case mix. Tick paralysis cases on the east coast frequently receive prophylactic antibiotics, hospitalised wildlife in Queensland and New South Wales share environments with domestic pets, and bushfire-affected animals in regional Victoria often present with secondary infections. Metagenomic profiling helps clinicians in Adelaide or Hobart align empirical choices with locally circulating resistance patterns rather than outdated antibiograms.

The technology also supports zoonotic risk investigations. Several resistance genes documented in canine and feline faeces, including blaCTX-M and qnr variants, overlap with human community-acquired infections. Households in suburban Brisbane or Canberra where owners share close contact with their pets benefit from this One Health perspective, allowing vets and GPs to discuss transmission risk with concrete data. For shelter medicine, group screening of intake samples identifies resistant clones before they spread through a facility.

Stewardship and the regulatory landscape

Antimicrobial stewardship has been formally embraced by the Australian Veterinary Association, and the Australian Pesticides and Veterinary Medicines Authority restricts several critically important antimicrobials. Metagenomic data align with these regulatory directions by identifying when broad-spectrum agents are unnecessary or when resistance patterns justify a restricted choice. State-level Veterinary Practice Acts in New South Wales, Victoria, and Western Australia all require evidence-based prescribing, and resistome reports contribute to that evidence base.

Veterinary teams also use the data to support antimicrobial use audits, a growing requirement for accredited hospitals. Tracking resistome changes before, during, and after a course of therapy provides an objective measure of stewardship impact. This evidence can be shared with hospital boards, industry programs, and One Health research initiatives operating across the Australasian region.

Limitations and the path to routine use

Metagenomic detection of a resistance gene does not confirm phenotypic expression, and some assays cannot distinguish chromosomal from plasmid carriage without long-read sequencing. Sample handling, host DNA contamination, and database curation all influence results, and reporting standards are still being defined. Clinicians should interpret resistome findings alongside culture and susceptibility data rather than in isolation.

Education will determine how quickly the technology integrates into everyday workflows. Platforms offering structured learning, downloadable resources, and certificates of completion help practitioners build confidence, which is why so many Australian vets turn to Hills ActivBiome for on-demand webinars and expert-led presentations. As sequencing costs fall and bioinformatics improves, resistome profiling is likely to become a standard component of chronic enteropathy workups, infection control in shelters, and antimicrobial stewardship programs across the country.